History
  • No items yet
midpage
Ista Pharmaceuticals, Inc. v. Food and Drug Administration
898 F. Supp. 2d 227
D.D.C.
2012
Read the full case

Background

  • ISTA sued FDA and related officials after FDA approved Coastal’s generic bromfenac ANDA referencing Xibrom/Bromday labeling; Coastal Pharmaceuticals intervened in the suit.
  • FDA approved ISTA’s NDA for Xibrom (bromfenac ophthalmic solution) in 2005 and later Bromday labeling in 2010 with three years of exclusivity for Bromday.
  • ISTA marketed Xibrom and Bromday concurrently for a period and challenged that the Xibrom labeling was not the “currently approved” label for reference purposes.
  • FDA determined Xibrom and Bromday were separate products and that Xibrom’s labeling remained “currently approved,” while Bromday’s labeling was not the baseline for exclusivity.
  • ISTA argued Xibrom was withdrawn for safety or effectiveness; FDA denied ISTA’s Citizen’s Petition; ISTA sought injunctive relief, and the court consolidated and reviewed under the APA.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether FDA’s approval of Coastal’s ANDA relying on Xibrom labeling was lawful ISTA contends Xibrom’s label was obsolete and not “currently approved” FDA relied on approved labeling and treated Xibrom and Bromday as separate products FDA lawful; Xibrom’s label was currently approved; Bromday distinct from Xibrom
Whether Xibrom was withdrawn for safety or effectiveness reasons ISTA argues Xibrom was withdrawn for safety/efficacy concerns ISTA voluntarily withdrew Xibrom; no safety/efficacy withdrawal by FDA Xibrom not withdrawn for safety/efficacy concerns; FDA consistent in allowing Coastal’s ANDA
Whether FDA properly denied ISTA’s Citizen’s Petition about reference labeling ISTA sought to block approval based on labeling interpretation FDA denied petition, finding labeling appropriate and safety considerations addressed FDA denial of the petition proper; no arbitrary or capricious action by FDA

Key Cases Cited

  • Marsh v. Ore. Natural Res. Council, 490 U.S. 360 (U.S. 1989) (court review under APA requires reasoned decision making)
  • Settles v. U.S. Parole Comm’n, 429 F.3d 1098 (D.C. Cir. 2005) (summary judgment appropriate for agency challenges under APA)
  • Fund for Animals v. Babbitt, 903 F. Supp. 96 (D.D.C. 1995) (summary judgment available in agency decision challenges)
Read the full case

Case Details

Case Name: Ista Pharmaceuticals, Inc. v. Food and Drug Administration
Court Name: District Court, District of Columbia
Date Published: Oct 17, 2012
Citation: 898 F. Supp. 2d 227
Docket Number: Civil Action No. 2011-0907
Court Abbreviation: D.D.C.